Methods of testing for allergic diseases, and therapeutic agents for treating same
US7172867B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jul 1, 2003 |
| Grant date | Feb 6, 2007 |
| Priority date | — |
| Expiry date | Aug 28, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Differential expression of genes whose expression is different in the activated eosinophils of atopic dermatitis patients was measured by comparative analysis using a gene chip. As a result, the TR3 and TINUR genes, whose expression is significantly elevated in activated eosinophils, were successfully identified. The present inventors discovered that these genes can be used to test for allergic disease and to screen candidate compounds for therapeutic agents for allergic disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.